To Evaluate the Best Metric for Inspection Time During a Diagnostic and/or Surveillance Upper Gastrointestinal Endoscopy (Age ≥ 18 Years, Informed Consent), Between Total Inspection Time Versus Withdrawal Time, for the Identification of Malignant Lesions
NCT ID: NCT06696209
Last Updated: 2025-06-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1290 participants
INTERVENTIONAL
2025-03-07
2026-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Upper gastrointestinal endoscopy (UGE) is the first-line examination for diagnosing upper gastrointestinal tract pathology, particularly oncological conditions. The European Society of Gastrointestinal Endoscopy (ESGE) and the United European Gastroenterology (UEG) have established that UGE quality is a priority, identifying specific quality parameters, such as the duration of the procedure, which is the most extensively studied parameter.
According to ESGE recommendations, all UGE reports should include the procedure time (goal: ≥90% of reports), which should be seven minutes or longer for surveillance of intestinal metaplasia. This time threshold follows a study that established a causal relationship between longer procedures (≥ seven minutes) and a higher detection rate of premalignant gastric conditions and lesions. Subsequent observational studies have generally shown that setting a minimum procedure time increases the detection rate of lesions.
The definition of procedure time varies between studies, being described as the time from intubation to extubation, but also as the time for withdrawing the endoscope from the second portion of the duodenum (D2) to extubation, also known as withdrawal time.
The hypothesis under study is that a better definition of the most appropriate time for a diagnostic UGE could standardize reports, improve malignant lesion detection rates, and reduce the rate of undiagnosed cancers, without any additional risk to patients.
Existing studies have been retrospective or comparative between different temporal cohorts, with no prospective or randomised comparative studies, nor any studies comparing the two existing metrics. Therefore, the aim of this study is to evaluate the best metric for inspection time during a diagnostic and/or surveillance UGE, between total inspection time versus withdrawal time, for the identification of malignant lesions.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Setting the Shortest Examination Time of Gastroscopy to Improve the Detection Rate of Upper Gastrointestinal Tumors
NCT04602299
SUrveillance of PREMalignant Stomach - Individualized Endoscopic Follow-up
NCT04613570
Optimal Initiation of Helicobacter Pylori Eradication After Endoscopic Resection for Gastric Neoplasm
NCT02921399
A Population-based, Multicenter Cohort Study of Combined Screening for Gastrointestinal Tumors
NCT05996458
Pilot Study of Stomach Cancer Early Detection and Prevention With Endoscopy
NCT05566899
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. First esophageal image;
2. First image of the second portion of the duodenum;
3. Last esophageal image.
The endoscopist will perform the UGE for as long as clinically necessary, which may be shortened if there is any need to interrupt the procedure for any clinical reason (such as intolerance or other), without any minimum or maximum time limits.
Although this is a non-interventional study that does not involve any modification to daily clinical practice, regarding the analyzed UGE, the study will be submitted for evaluation by the Ethics Committee of the Portuguese Institute of Oncology of Coimbra and will be performed in accordance with the principles of the Helsinki Declaration. All analyzed data will be kept confidential, and the investigators will ensure the anonymity of the patients included during data analysis and publication.
This study aims to define the best metric for quantifying the most appropriate time for performing a diagnostic or surveillance UGE. To our knowledge, all existing studies on the topic of procedure time in UGE are observational. This study will be the first randomised clinical trial in this area, with the purpose of providing a systematic evaluation that will contribute to the optimization of quality measures.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Analysis of the withdrawal time of the Upper Gastrointestinal Endoscopy
Analysis of the withdrawal time of the Upper Gastrointestinal Endoscopy
Time of last esophageal image - time of first image of the second portion of the duodenum.
Upper gastrointestinal endoscopy: Common Practices
Execution of UGE using high-resolution endoscopes, with the option of virtual chromoendoscopy, according with the physician's preference. Possible optimization of visualization with washing and/or the use of simethicone or similar, as pre-medication or during the examination, according with the physician's preference. Patients will be randomised to one of the following measurements-total time versus withdrawal time-in a parallel 1:1 scheme.
The allocation of the randomisation group will be computer-generated. The endoscopist must record the time at which the following three anatomical structures are reached (either by noting during the procedure or based on the information in the photographic documentation), before any biopsies or therapeutic interventions, in the format xxh:xxmin:xxsec:
1. First esophageal image;
2. First image of the second portion of the duodenum;
3. Last esophageal image.
Analysis of the total time of the Upper Gastrointestinal Endoscopy
Analysis of the total time of the Upper Gastrointestinal Endoscopy
Time of last esophageal image - time of first esophageal image
Upper gastrointestinal endoscopy: Common Practices
Execution of UGE using high-resolution endoscopes, with the option of virtual chromoendoscopy, according with the physician's preference. Possible optimization of visualization with washing and/or the use of simethicone or similar, as pre-medication or during the examination, according with the physician's preference. Patients will be randomised to one of the following measurements-total time versus withdrawal time-in a parallel 1:1 scheme.
The allocation of the randomisation group will be computer-generated. The endoscopist must record the time at which the following three anatomical structures are reached (either by noting during the procedure or based on the information in the photographic documentation), before any biopsies or therapeutic interventions, in the format xxh:xxmin:xxsec:
1. First esophageal image;
2. First image of the second portion of the duodenum;
3. Last esophageal image.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Analysis of the withdrawal time of the Upper Gastrointestinal Endoscopy
Time of last esophageal image - time of first image of the second portion of the duodenum.
Analysis of the total time of the Upper Gastrointestinal Endoscopy
Time of last esophageal image - time of first esophageal image
Upper gastrointestinal endoscopy: Common Practices
Execution of UGE using high-resolution endoscopes, with the option of virtual chromoendoscopy, according with the physician's preference. Possible optimization of visualization with washing and/or the use of simethicone or similar, as pre-medication or during the examination, according with the physician's preference. Patients will be randomised to one of the following measurements-total time versus withdrawal time-in a parallel 1:1 scheme.
The allocation of the randomisation group will be computer-generated. The endoscopist must record the time at which the following three anatomical structures are reached (either by noting during the procedure or based on the information in the photographic documentation), before any biopsies or therapeutic interventions, in the format xxh:xxmin:xxsec:
1. First esophageal image;
2. First image of the second portion of the duodenum;
3. Last esophageal image.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnostic or surveillance upper gastrointestinal endoscopy for premalignant conditions
* Informed consent for the execution of the upper gastrointestinal endoscopy and participation in the study
Exclusion Criteria
* Known or suspected neoplasia
* Therapeutic procedure (polypectomy, argon plasma coagulation, hemostasis, others)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Portuguese Oncology Institute, Coimbra
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maria Inês Viegas
Medical Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Portuguese Institute of Oncology
Coimbra, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PortugueseOIC 006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.